Caltalks' interview with our CEO
BMG Pharma: leadership in the Oral Care and Aesthetic Medicine sector
The double soul of BMG Pharma and our future challenges
Mastrodonato (BMG Pharma): without innovation you cannot be successful
The latest news
BMG Pharma: innovation, research, growth and commitment to the future
A great success for BMG Pharma News!
BMG Pharma launches new “Hyaluromimethic” technology
Since 2011, BMG Pharma has been an Italian excellence serving the biotechnology sector, which is bringing great innovations to the biopolymers sector.
Follow the Sole24Ore interview with our CEO Marco Mastrodonato regarding the new Hyaluromimethic ® technological platform and the projects in development.
BMG Pharma
We Make it Happen
Torviscosa - BMG Pharma reaches patent record
A business plan focused on commercial expansion, research and development. In two years, the company created 4 new patents and registered 36 innovative products, as well as launching 37 on an international scenario.
BMG Pharma and Massimo Doris join the company
Massimo Doris, CEO of Banca Mediolanum buys 2% of the share package, creating a corporate form with the company specializing in the production of new biomaterials derived from hyaluronic acid.
